Drug:
Reaction: INFLUENZA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26912838 |
CA |
50 | 2 |
Pneumonia, Influenza, Bacterial infection, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 102 | 26913034 |
ZA |
15 | 1 |
Diabetic ketoacidosis, Injection site hypertrophy, Lack of administration site rotation, Blood glucose increased, Glycosylated haemoglobin increased, Influenza, |
||||
INSULIN GLULISINE, |
||||
| 103 | 26913302 |
CA |
1 | |
Influenza, |
||||
RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, PYRIDOSTIGMINE BROMIDE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 104 | 26913380 |
EU |
80 | 1 |
Influenza, Basal cell carcinoma, COVID-19, Disease progression, Obstructive sleep apnoea syndrome, Osteoarthritis, Device related infection, Rhinitis, Road traffic accident, Prostatic specific antigen increased, Inguinal hernia, |
||||
NINTEDANIB, NINTEDANIB, OXYGEN, 0XYGEN, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, FLUCONAZOLE, PREDNISONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FENTANYL, AZELASTINE HYDROCHLORIDE, AZELASTINE, AZELASTINE HYDROCHLORIDE, AZELASTINE, LORAZEPAM, PANTOPRAZOLE, |
||||
| 105 | 26913495 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Anxiety, Epilepsy, Ankle fracture, Migraine, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Vomiting, Nausea, Hypertension, Diarrhoea, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Foot fracture, Blood alkaline phosphatase increased, Dizziness, Haematocrit decreased, Haemoglobin decreased, White blood cell count decreased, Malaise, Headache, Abnormal behaviour, Emotional distress, Skin discolouration, Depression, Ligament sprain, Myopia, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Asphyxia, Choking, Petit mal epilepsy, Metastases to lung, Neoplasm malignant, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Depressed mood, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Electric shock sensation, Full blood count decreased, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Pain, Fluid retention, Fat tissue increased, Dry eye, Back pain, Abdominal discomfort, Diarrhoea, Fatigue, Headache, Dysgeusia, Memory impairment, Aversion, Blood sodium increased, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Elliptocytosis, Discomfort, Atrioventricular block first degree, Red cell distribution width increased, Red blood cell sedimentation rate increased, Blood glucose increased, Gastrointestinal disorder, Mean cell volume increased, Rouleaux formation, Limb deformity, Oral herpes, Ill-defined disorder, Thyroid mass, Visual impairment, Decreased immune responsiveness, Neoplasm, Arthritis, Gingival disorder, Pruritus, Hypersensitivity, Pyrexia, Red blood cell count decreased, Lymphocyte count decreased, Dry skin, Pain in extremity, Vision blurred, Herpes virus infection, Viral diarrhoea, Colitis, Chills, Agitation, Confusional state, Oesophagitis, Gastrooesophageal reflux disease, Stress, Catheter site pain, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Weight decreased, Nasopharyngitis, Alopecia, Tension headache, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, ERGOCALCIFEROL, CALCIUM, |
||||
| 106 | 26913537 |
BR |
1 | |
Ankylosing spondylitis, Haemorrhoids, Influenza, Memory impairment, Inappropriate schedule of product administration, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 107 | 26913717 |
EU |
66 | 2 |
Influenza, Pneumonia, Pneumonia influenzal, Off label use, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 108 | 26913871 |
US |
40 | 2 |
Influenza, Ear infection, |
||||
SIBEPRENLIMAB, |
||||
| 109 | 26914098 |
US |
47 | 1 |
Body temperature increased, Asthenia, External ear pain, Influenza, |
||||
SIBEPRENLIMAB, |
||||
| 110 | 26914578 |
CA |
31 | |
Hernia, Influenza, Nasopharyngitis, Inappropriate schedule of product administration, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, AMLODIPINE, ALBUTEROL SULFATE, MONTELUKAST, |
||||
| 111 | 26914585 |
CO |
8 | 1 |
Influenza, Thrombocytopenia, |
||||
ROMIPLOSTIM, |
||||
| 112 | 26904701 |
1 | ||
Psychotic disorder, Schizophrenia, Suicide attempt, Hallucination, auditory, Hallucination, visual, Seizure, Confusional state, Catatonia, Influenza, Diarrhoea, Insomnia, |
||||
MONTELUKAST SODIUM, |
||||
| 113 | 26904959 |
US |
2 | |
Influenza, |
||||
TROFINETIDE, TROFINETIDE, |
||||
| 114 | 26904991 |
CO |
39 | 2 |
Diarrhoea, Pyrexia, Nausea, Off label use, Vomiting, Maternal exposure during pregnancy, Abdominal pain, Headache, Pain, Malaise, Influenza, |
||||
CERTOLIZUMAB PEGOL, BACILLUS SUBTILIS, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, |
||||
| 115 | 26904993 |
US |
1 | |
Pneumonia, Influenza, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, FINASTERIDE, MELOXICAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, QUETIAPINE, |
||||
| 116 | 26905020 |
CO |
75 | 2 |
Cough, Influenza, Therapy interrupted, Product dispensing issue, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LOSARTAN, |
||||
| 117 | 26905024 |
GB |
2 | |
Influenza, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 118 | 26905451 |
US |
12 | 1 |
Cardiac failure, Transient ischaemic attack, Decreased appetite, Diarrhoea, Vomiting, Influenza, Malaise, Incorrect dose administered, |
||||
VAMOROLONE, VAMOROLONE, ZOLEDRONIC ACID, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE, CARVEDILOL, GIVINOSTAT, LISINOPRIL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SPIRONOLACTONE, ERGOCALCIFEROL, |
||||
| 119 | 26905658 |
AR |
48 | 2 |
Pneumonia, Influenza, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 120 | 26905784 |
CO |
77 | 2 |
Blindness, Deafness, Chest injury, Fall, Viral infection, Back injury, Facial pain, Joint swelling, Influenza, Pain, Arthralgia, Plantar fasciitis, Gastrooesophageal reflux disease, Illness, Abdominal discomfort, Dizziness, Erythema, Burning sensation, Rash, Ocular icterus, Lacrimation increased, Photophobia, Headache, Gingival pain, Amnesia, Alopecia, Odynophagia, Facial asymmetry, Rhinorrhoea, Gait disturbance, Depression, Skin exfoliation, Coordination abnormal, |
||||
DENOSUMAB, |
||||
| 121 | 26906154 |
AR |
45 | 2 |
Parkinson^s disease, Influenza, Product dose omission issue, |
||||
INFLIXIMAB, |
||||
| 122 | 26906283 |
CA |
25 | |
Hospitalisation, Rectal injury, Arthralgia, Influenza, Muscle spasms, Inflammation, Proctalgia, Symptom recurrence, Weight increased, Fatigue, Headache, Abdominal pain, Insomnia, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, PREDNISONE, |
||||
| 123 | 26906503 |
EU |
46 | 2 |
Pneumocystis jirovecii infection, Retroperitoneal cancer, Condition aggravated, Campylobacter bacteraemia, Immunodeficiency, Candida infection, Retroperitoneal mass, Mucosal inflammation, Respiratory tract infection, COVID-19, Escherichia urinary tract infection, Retroperitoneal lymphadenopathy, Blood immunoglobulin M decreased, Blood immunoglobulin A decreased, Anaemia, Viral infection, Fungal infection, Serum ferritin decreased, Acute sinusitis, Vascular purpura, Blood immunoglobulin G decreased, Clostridium test positive, Influenza, Lymphadenopathy, |
||||
RITUXIMAB, |
||||
| 124 | 26906580 |
AU |
2 | |
Gait disturbance, Flushing, Headache, Vomiting, Dizziness, Decreased appetite, Pain, Influenza, Nausea, Pyrexia, Pain, Headache, |
||||
| 125 | 26906874 |
CA |
9 | 2 |
Neoplasm malignant, Pyrexia, Influenza, Drug ineffective, Abdominal pain, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 126 | 26907804 |
US |
2 | |
Anaphylactic reaction, Migraine, Asthma, Speech disorder, Influenza, Head discomfort, |
||||
ONABOTULINUMTOXINA, GALCANEZUMAB-GNLM, TOPIRAMATE, |
||||
| 127 | 26908146 |
US |
4 | 1 |
Dermatitis, Nasopharyngitis, Influenza, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 128 | 26909304 |
US |
25 | 2 |
Influenza, Pyrexia, Eczema, Pruritus, Dry skin, Asthma, |
||||
DUPILUMAB, DUPILUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, LEVOCETIRIZINE DIHYDROCHLORIDE, ROFLUMILAST, |
||||
| 129 | 26904123 |
US |
39 | 1 |
Myalgia, Muscle spasms, Respiratory tract infection, Influenza, Cough, Productive cough, Conjunctivitis, Arthralgia, |
||||
DUPILUMAB, |
||||
| 130 | 26904376 |
CO |
69 | 2 |
Influenza, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 131 | 26913978 |
44 | 1 | |
Influenza, Nasopharyngitis, Myalgia, Skin warm, |
||||
LENACAPAVIR SODIUM, |
||||
| 132 | 26903580 |
US |
55 | 2 |
Surgery, Pancreatitis, Suspected COVID-19, Product storage issue, Incorrect dose administered, Stress, Visual impairment, Malaise, Influenza, Breast cancer, Pancreatic disorder, Radiotherapy, |
||||
PANCRELIPASE, |
||||
| 133 | 26897572 |
US |
34 | 2 |
Influenza, Pyrexia, Rhinorrhoea, Nasal congestion, Injection site pain, Product prescribing issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 134 | 26897659 |
ZA |
49 | 1 |
Death, Influenza, |
||||
DARBEPOETIN ALFA, |
||||
| 135 | 26897977 |
CA |
60 | |
Colitis ulcerative, Osteoarthritis, Arthralgia, Arthritis viral, Diarrhoea, Influenza, Nasopharyngitis, Inappropriate schedule of product administration, Intentional product use issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ROSUVASTATIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 136 | 26898110 |
ZA |
65 | |
Spinal operation, Hospitalisation, Condition aggravated, Chest pain, Influenza, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CYCLOSPORINE, |
||||
| 137 | 26898322 |
CA |
69 | 2 |
Gait disturbance, Musculoskeletal pain, Back pain, Pain in extremity, Incorrect dose administered, Alopecia, Dysstasia, Pain, Insomnia, Drug ineffective, Vitamin C increased, Madarosis, Nail discolouration, Nail disorder, Onychomadesis, Pollakiuria, Urine analysis abnormal, Rash macular, Micturition urgency, Influenza, Pneumonia, |
||||
MIRTAZAPINE, MIRTAZAPINE, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 138 | 26898603 |
US |
55 | 2 |
Influenza, |
||||
TIRZEPATIDE, |
||||
| 139 | 26898710 |
US |
75 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 140 | 26899091 |
CA |
32 | 2 |
Pneumonia, Nasal congestion, Infection, Sinusitis, Sleep disorder due to a general medical condition, Vertigo, Urticaria, Vomiting, Rhinitis, Therapeutic product effect decreased, Nasopharyngitis, Decreased activity, Oropharyngeal pain, Stress, Dyspnoea exertional, Eczema, Feeding disorder, Psoriasis, Dizziness, Full blood count abnormal, Pain, Cough, Diarrhoea, Influenza, Tooth abscess, Ear infection, Drug ineffective, Product administration error, Asthma, Middle insomnia, Abdominal pain, Loss of personal independence in daily activities, Upper-airway cough syndrome, Wheezing, Productive cough, Migraine, Therapeutic response decreased, Blood pressure increased, Eosinophil count abnormal, Bacterial infection, Terminal insomnia, Dyspnoea, Anxiety, Fungal infection, Urinary tract infection, Musculoskeletal chest pain, Restrictive pulmonary disease, Nasal discharge discolouration, Emphysema, Forced expiratory volume decreased, Rales, Malaise, Tachycardia, Heart rate increased, Sleep disorder, Obstructive airways disorder, |
||||
FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMALIZUMAB, |
||||
| 141 | 26899167 |
US |
2 | |
Pulmonary hypertension, Influenza, |
||||
TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, MACITENTAN, NORETHINDRONE, ERGOCALCIFEROL, SERTRALINE HYDROCHLORIDE, ERGOCALCIFEROL, SILDENAFIL CITRATE, SILDENAFIL, FAMOTIDINE, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, BUDESONIDE, LORATADINE, LORATADINE TABLET, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYGEN, 0XYGEN, CETIRIZINE HCL, CETIRIZINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 142 | 26899201 |
CA |
15 | 2 |
Abdominal pain, Pyrexia, Nausea, Vomiting, Influenza, Viral infection, Product use issue, |
||||
INFLIXIMAB, |
||||
| 143 | 26899264 |
US |
2 | |
Intestinal anastomosis, Rhinorrhoea, Vein disorder, Pain in extremity, Ear discomfort, Influenza, Skin disorder, Eye inflammation, Carditis, Pneumonitis, Pharyngeal inflammation, Inflammation, Post procedural inflammation, Colitis, |
||||
RISANKIZUMAB-RZAA, |
||||
| 144 | 26899310 |
US |
63 | 2 |
Influenza, Feeling cold, Pain, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, FUROSEMIDE, GABAPENTIN, GLIPIZIDE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, EMPAGLIFLOZIN, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, LOSARTAN POTASSIUM, LOSARTAN, METHOCARBAMOL, METHOCARBAMOL TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MONTELUKAST SODIUM, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RANOLAZINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TOPIRAMATE, ERGOCALCIFEROL, |
||||
| 145 | 26899820 |
CA |
49 | 2 |
Dyspnoea, Hepatic enzyme increased, Influenza, Nausea, Vomiting, Off label use, Somnolence, Cystitis, Pyrexia, Gastric dilatation, Insomnia, Breakthrough pain, Contusion, Musculoskeletal discomfort, Inappropriate schedule of product administration, Ankylosing spondylitis, Renal impairment, Hypokalaemia, Fall, Loss of consciousness, Lower respiratory tract infection, Pruritus, Dysphagia, Skin wound, Aphthous ulcer, Asthenia, Hypoaesthesia, Peripheral swelling, Dyspnoea exertional, Mobility decreased, Swelling, |
||||
MIRTAZAPINE, INFLIXIMAB, INFLIXIMAB, BACLOFEN, CLONAZEPAM, FAMOTIDINE, FERROUS SULFATE, MELATONIN, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, ALBUTEROL, SERTRALINE, ERGOCALCIFEROL, CELECOXIB, HYDROMORPHONE HYDROCHLORIDE, PREGABALIN, |
||||
| 146 | 26900201 |
JP |
87 | 1 |
Pneumonia, Influenza, Infection, Respiratory tract infection, Urinary tract infection, |
||||
RAVULIZUMAB, ECULIZUMAB, DANICOPAN, |
||||
| 147 | 26900917 |
UY |
48 | 2 |
Asthmatic crisis, Influenza, Eye infection viral, Oropharyngeal pain, Ear pain, |
||||
UPADACITINIB, |
||||
| 148 | 26900942 |
JP |
58 | 2 |
Influenza, Infection, Urinary tract infection, |
||||
RAVULIZUMAB, ECULIZUMAB, DANICOPAN, |
||||
| 149 | 26901076 |
US |
2 | |
Influenza, Sleep terror, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 150 | 26901177 |
US |
2 | |
Influenza, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 151 | 26901248 |
US |
0 | 2 |
Pyrexia, Rotavirus infection, Influenza, Pyrexia, Influenza, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 152 | 26901305 |
US |
0 | 2 |
Influenza, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 153 | 26901308 |
US |
3 | 2 |
Influenza, Flatulence, Diarrhoea, Irritability, Product administered to patient of inappropriate age, Inappropriate schedule of product administration, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 154 | 26901462 |
US |
0 | 2 |
Infantile spitting up, Influenza, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 155 | 26901621 |
US |
1 | |
Influenza, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 156 | 26901706 |
DZ |
1 | |
Influenza, Product use issue, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 157 | 26901711 |
DZ |
0 | 1 |
Influenza, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 158 | 26901713 |
DZ |
0 | 2 |
Influenza, Influenza, Product use issue, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 159 | 26901714 |
DZ |
1 | 1 |
Influenza, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 160 | 26902068 |
EU |
16 | 2 |
Cachexia, Amenorrhoea, Hypoalbuminaemia, Autoimmune hepatitis, Pneumonia streptococcal, Crohn^s disease, Anaemia, Oedema peripheral, COVID-19, Influenza, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 161 | 26902312 |
BR |
||
Cardiac failure, Influenza, Product storage issue, |
||||
INSULIN LISPRO, |
||||
| 162 | 26891993 |
US |
2 | |
Lung disorder, Influenza, Product dose omission issue, |
||||
BELIMUMAB, |
||||
| 163 | 26892391 |
US |
8 | 2 |
COVID-19 pneumonia, Pneumonia cytomegaloviral, Influenza, Septic shock, |
||||
RITUXIMAB, PREDNISONE, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METHYLPREDNISOLONE, AZATHIOPRINE, |
||||
| 164 | 26892680 |
EU |
||
Influenza, Pneumonia, |
||||
ZANUBRUTINIB, |
||||
| 165 | 26892695 |
CA |
79 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Multiple allergies, Gastrooesophageal reflux disease, Dyspepsia, Pruritus, Influenza, Malaise, Nausea, Hepatic enzyme increased, |
||||
NINTEDANIB, |
||||
| 166 | 26893686 |
US |
||
Death, Cytokine release syndrome, Influenza, Respiratory failure, Immune effector cell-associated neurotoxicity syndrome, |
||||
GLOFITAMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, OXALIPLATIN, |
||||
| 167 | 26893793 |
EU |
2 | |
Gastrointestinal inflammation, Influenza, |
||||
| 168 | 26893980 |
US |
25 | 2 |
Maternal exposure before pregnancy, Pre-eclampsia, Influenza, Lyme disease, Joint effusion, Maternal exposure during pregnancy, |
||||
SATRALIZUMAB, BACLOFEN, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, FAMOTIDINE, |
||||
| 169 | 26894224 |
CA |
41 | 1 |
Pneumonia, Influenza, Sinonasal obstruction, Sinusitis, Asthma, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 170 | 26894429 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Product use issue, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
LISINOPRIL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, RAMIPRIL, |
||||
| 171 | 26895678 |
81 | 2 | |
Pneumonia, Influenza, |
||||
LENALIDOMIDE, |
||||
| 172 | 26895949 |
ZA |
16 | 1 |
Juvenile idiopathic arthritis, Varicella, Ageusia, Joint swelling, Pain in extremity, Mobility decreased, Infection, Illness, Skin lesion, Influenza, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 173 | 26896234 |
BR |
42 | 2 |
Cholelithiasis, Helicobacter infection, Suspected COVID-19, Biliary dilatation, Diabetes mellitus, Malaise, Malaise, Constipation, Nausea, Dizziness, Dizziness, Asthenia, Asthenia, Abdominal pain upper, Abdominal pain upper, Viral infection, Influenza, Leiomyoma, Inguinal hernia, Thyroid cyst, Breast cyst, Groin pain, Pain in extremity, Retching, Hypermetabolism, Fatigue, Headache, Crying, Cough, Pain, Muscle fatigue, Anxiety, Fear, Eating disorder, Hypertension, Blood glucose fluctuation, Product dose omission issue, Needle issue, Injury associated with device, Product leakage, Product solubility abnormal, Product physical consistency issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, PANTOPRAZOLE, |
||||
| 174 | 26896371 |
CA |
34 | 2 |
Angina unstable, Hypertension, Gait inability, Hyperhidrosis, Hypersensitivity, Pharyngeal swelling, Swollen tongue, Asthenia, Myocardial infarction, General physical health deterioration, Pain, Malaise, Feeling abnormal, Swelling face, Lymphadenopathy, Dysstasia, Pyrexia, Insomnia, Chest pain, Dizziness, Tremor, Abdominal discomfort, Weight decreased, Circadian rhythm sleep disorder, Rhinitis allergic, Influenza, Menstruation irregular, Immune system disorder, Obstructive airways disorder, Heart rate increased, Pneumonitis, Haemorrhoids, Respiratory disorder, Diarrhoea, Dysmenorrhoea, Cough, Joint swelling, Nasopharyngitis, Rash, Somnolence, Urticaria, Asthma, Dyspnoea, Speech disorder, Cardiac failure, Swelling, Product dose omission issue, Incorrect dose administered, Hypertension, Inappropriate schedule of product administration, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, IPRATROPIUM BROMIDE, |
||||
| 175 | 26896546 |
CA |
76 | 1 |
Cardiac failure congestive, Hospitalisation, Influenza, Nasopharyngitis, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 176 | 26896561 |
US |
42 | 1 |
Influenza, Back pain, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 177 | 26886890 |
CA |
69 | |
Animal bite, Anal abscess, Infection, Aphthous ulcer, Arthralgia, Influenza, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 178 | 26886897 |
US |
89 | 1 |
Chronic obstructive pulmonary disease, Influenza, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, AMLODIPINE BESYLATE, INSULIN LISPRO, TAMSULOSIN HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, FINASTERIDE, ERGOCALCIFEROL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ATORVASTATIN CALCIUM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, BRIMONIDINE TARTRATE, MUPIROCIN, MUPIROCIN CALCIUM, WARFARIN SODIUM, WARFARIN, OXYGEN, 0XYGEN, LATANOPROST, PREDNISONE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FUROSEMIDE, CLOPIDOGREL, |
||||
| 179 | 26887686 |
CA |
32 | 2 |
Abdominal pain, Anxiety, Asthma, Bacterial infection, Blood pressure increased, Cough, Decreased activity, Diarrhoea, Dizziness, Dyspnoea, Dyspnoea exertional, Ear infection, Eczema, Emphysema, Eosinophil count abnormal, Feeding disorder, Forced expiratory volume decreased, Full blood count abnormal, Fungal infection, Heart rate increased, Infection, Influenza, Loss of personal independence in daily activities, Malaise, Migraine, Middle insomnia, Musculoskeletal chest pain, Nasal congestion, Nasal discharge discolouration, Nasopharyngitis, Pneumonia, Obstructive airways disorder, Oropharyngeal pain, Pain, Productive cough, Psoriasis, Rales, Restrictive pulmonary disease, Rhinitis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Stress, Tachycardia, Terminal insomnia, Tooth abscess, Upper-airway cough syndrome, Urinary tract infection, Urticaria, Vertigo, Vomiting, Wheezing, Drug ineffective, Therapeutic product effect decreased, Therapeutic response decreased, Product administration error, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, OMALIZUMAB, |
||||
| 180 | 26888145 |
US |
61 | 2 |
Influenza, Hypotension, |
||||
| 181 | 26888364 |
CA |
69 | 2 |
Drug ineffective, Incorrect dose administered, Nail disorder, Influenza, Pain, Rash macular, Dysstasia, Nail discolouration, Pollakiuria, Pneumonia, Gait disturbance, Urine analysis abnormal, Micturition urgency, Onychomadesis, Back pain, Madarosis, Pain in extremity, Insomnia, Musculoskeletal pain, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, MIRTAZAPINE, |
||||
| 182 | 26888742 |
CA |
60 | 2 |
Influenza, Cough, Fatigue, Productive cough, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 183 | 26889329 |
JP |
12 | 1 |
Status epilepticus, Off label use, Prescribed underdose, Influenza, Rhinorrhoea, Scoliosis, Conjunctivitis, Asteatosis, Iron deficiency anaemia, Rhinitis allergic, Nausea, Decreased appetite, Epilepsy, |
||||
TOPIRAMATE, EPINASTINE HYDROCHLORIDE, POTASSIUM BROMIDE, STIRIPENTOL, VALPROATE SODIUM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), FLUTICASONE FUROATE, |
||||
| 184 | 26889330 |
US |
2 | |
Influenza, Chronic obstructive pulmonary disease, |
||||
DUPILUMAB, |
||||
| 185 | 26889733 |
US |
93 | 2 |
Cough, Influenza, |
||||
DUPILUMAB, |
||||
| 186 | 26889934 |
CO |
6 | 2 |
Bronchiolitis, Urinary tract infection, Influenza, Cough, |
||||
PALIVIZUMAB, |
||||
| 187 | 26889942 |
CA |
51 | 2 |
Acne, Urticaria, Urticaria, Urticaria, Respiratory disorder, Pyrexia, Productive cough, Product administered at inappropriate site, Pneumonia, Peripheral swelling, Off label use, Musculoskeletal pain, Inflammation, Inappropriate schedule of product administration, Hypercholesterolaemia, Cough, Brain fog, Arthralgia, Amnesia, Gait disturbance, Drug effect less than expected, Erythema, Erythema, Fatigue, Feeling hot, Gallbladder disorder, Hair disorder, Headache, Hot flush, Influenza, Musculoskeletal stiffness, Amenorrhoea, Myalgia, Nasal congestion, Nasal discharge discolouration, Pain, Paraesthesia, Pruritus, Pruritus, Pruritus, Pruritus, Pruritus, Asthma, Pruritus, Skin plaque, Skin plaque, Skin plaque, Skin plaque, Skin sensitisation, Stress, Urticaria, Urticaria, Vaginal haemorrhage, Behaviour disorder, Weight increased, Bronchitis, Chills, Chills, Choking, Dyspnoea, |
||||
CYCLOSPORINE, CYCLOSPORINE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, |
||||
| 188 | 26890160 |
91 | 2 | |
Deep vein thrombosis, Asthenia, Skin ulcer, Localised infection, Influenza, Stress, Anxiety, Pain, Dyspnoea, |
||||
LENALIDOMIDE, ENOXAPARIN SODIUM, WARFARIN, |
||||
| 189 | 26890461 |
CA |
78 | 1 |
Influenza, |
||||
ADALIMUMAB-AFZB, |
||||
| 190 | 26890506 |
BR |
42 | 2 |
Cholelithiasis, Helicobacter infection, Suspected COVID-19, Biliary dilatation, Diabetes mellitus, Malaise, Malaise, Constipation, Nausea, Dizziness, Dizziness, Asthenia, Asthenia, Abdominal pain upper, Abdominal pain upper, Viral infection, Influenza, Leiomyoma, Inguinal hernia, Thyroid cyst, Breast cyst, Groin pain, Pain in extremity, Retching, Hypermetabolism, Fatigue, Headache, Crying, Cough, Pain, Muscle fatigue, Anxiety, Fear, Eating disorder, Blood glucose fluctuation, Hypertension, Product leakage, Needle issue, Product dose omission issue, Injury associated with device, Product solubility abnormal, Product physical consistency issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, PANTOPRAZOLE, |
||||
| 191 | 26890636 |
US |
||
Influenza, Product storage error, |
||||
| 192 | 26890682 |
EU |
1 | 1 |
Sialoadenitis, Upper respiratory tract infection, Pyrexia, Influenza, |
||||
| 193 | 26890882 |
US |
55 | 2 |
Influenza, |
||||
TUCATINIB, |
||||
| 194 | 26891251 |
US |
62 | 2 |
Loss of consciousness, Gastric ulcer, Abdominal pain upper, Biliary colic, Hypersomnia, Somnolence, Kidney infection, Mental status changes, Ligament sprain, Wound, Blood pressure decreased, Fall, Head injury, Emotional distress, Feeling abnormal, Sciatica, Blood glucose increased, Influenza, Blood pressure fluctuation, Ear discomfort, Musculoskeletal chest pain, Myalgia, Pain, Rash pruritic, Glycosylated haemoglobin increased, Dry skin, Pruritus, Drug interaction, Arthralgia, Blood glucose decreased, Decreased appetite, Alopecia, Lethargy, Fatigue, Malaise, |
||||
TIRZEPATIDE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, BUPRENORPHINE HYDROCHLORIDE, EMPAGLIFLOZIN, ALPRAZOLAM, |
||||
| 195 | 26891515 |
US |
55 | 2 |
Mineral supplementation, Pneumonia, Influenza, Skin disorder, Adverse event, |
||||
INEBILIZUMAB, INEBILIZUMAB, |
||||
| 196 | 26881426 |
US |
45 | 2 |
Influenza, Aphonia, |
||||
DUPILUMAB, |
||||
| 197 | 26882086 |
US |
2 | |
Influenza, Feeding disorder, |
||||
TIRZEPATIDE, |
||||
| 198 | 26882801 |
|||
Death, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Respiratory failure, Influenza, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GLOFITAMAB, OXALIPLATIN, |
||||
| 199 | 26883050 |
US |
2 | |
Influenza, |
||||
TIRZEPATIDE, |
||||
| 200 | 26883137 |
BR |
37 | 1 |
Influenza, Dyspnoea, Product use issue, Device delivery system issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30